IRCT20100127003210N16尚未招募2 期
Cytisine versus nicotine for smoking cessation in hospitalized psychiatric patients.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •At least 18 years of age
- •Daily smokers
- •Motivated to quit
排除标准
- •Pregnant or breast-feeding women
- •Enrolled in another cessation program or study
- •Systolic blood pressure above 150 mm Hg
- •Diastolic blood pressure above 100 mm Hg
- •Cardiovascular event in the 2 weeks before study enrollment
研究者
相似试验
尚未招募
3 期
Efficacy of CYTISINE for Smoking Cessation through Downward Titration versus Simplified Three times daily Regimen : Open-label Randomized Clinical TrialSmokerscytisine,Smokers ,Smoking CessationTCTR20240711001Thai Health Promotion Foundation120
已完成
1 期
Cytisine as a smoking cessation aid: measuring blood levels, craving, withdrawal and mood over a course of treatmentSmokingOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12613000002785niversity of Auckland12
进行中（未招募）
1 期
Comparison of Varenicline and Cytisine effectiveness on nicotine smoking cessation in Primary health care - randomized controlled trialTobacco addictionEUCTR2019-003720-20-SIniversity of Zagreb School of Medicine380
进行中（未招募）
1 期
Cytisine in prolonged dosage versus Nicotine Replacement Therapy in nicotine-dependent patients with Chronic Kidney Disease - single-center, randomized, non-inferiority clinical trial.icotine dependence, Chronic Kidney DiseaseMedDRA version: 20.0Level: PTClassification code: 10057852Term: Nicotine dependence Class: 100000004873MedDRA version: 21.1Level: PTClassification code: 10064848Term: Chronic kidney disease Class: 100000004857CTIS2023-509235-39-00arodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy292
招募中
不适用
Analysis and Evaluation of Smoking Treatment With CytisineModerate or Severe Tobacco Use DisorderNCT06439303Regina Elena Cancer Institute65